, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Financial Position As at December 31 Change 2019 2018 MB MB MB % Total assets 525.87 195.47 330.40 169.03

. Financial Position As at December 31 Change 2019 2018 MB MB MB % Total assets 525.87 195.47 330.40 169.03 Total liabilities 60.13 88.48 (28.35) (32.04) Total shareholders’ equity 465.74 106.99 358.75 335.31

investors. However, the underwriter is required to purchase those shares at a later date, resulting in higher demand when share price is below initial public offering price. In contrary, higher number of

loss on change in status of investments as the valuation of the investments is valuated at fair value or Baht 5 million. Furthermore, the company suffer from loss on recognition of other comprehensive

Financial Position Analysis Unit : MB As at 30 September 2018 As at 31 December 2017 Change MB % Cash and cash equivalents 92.16 124.63 -32.47 -26.06% Current investment 155.85 252.71 -96.86 -38.33

amount for all project in 2018 is approximately Baht 220 million. Financial Position Analysis Unit : MB As at 30 June 2018 As at 31 December 2017 Change MB % Cash and cash equivalents 71.86 124.63 -52.77

position of GFPT Public Company Limited and its subsidiary companies As at June 30, 2017 and December 31, 2016 As at Jun 30, 2017 As at Dec 31, 2016 Change MB % MB % MB % Cash and Cash Equivalent 590 3.49

subsidiary companies As at June 30, 2019 and December 31, 2018 As at Jun 30, 2019 As at Dec 31, 2018 Change MB % MB % MB % Cash and Cash Equivalent 1,514.26 8.23 1,240.09 6.84 274.17 22.11 Trade and Other

of GFPT Public Company Limited and its subsidiary companies As at September 30, 2019 and December 31, 2018 As at Sep 30, 2019 As at Dec 31, 2018 Change MB % MB % MB % Cash and Cash Equivalents 1,559.80

at June 30, 2018, the consolidated debt to equity ratio was 0.45 time and the consolidated net debt to equity ratio was considerably low at 0.30 time. Financial Highlights 2Q 2018 2Q 2017 Change 6M